| Original language | English |
|---|---|
| Pages (from-to) | 1680-1693 |
| Number of pages | 14 |
| Journal | International Journal of Cancer |
| Volume | 147 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2 Mar 2020 |
Funding
We are indebted to Mira Stojanovic, Irene Herbacek and Gerhard Zeitler for competent technical assistance. This project was supported by the Austrian Science Fund (FWF; P30105 and P19920 to W.B., I4164 to J.G., P28853 to C.R.K) and by Herzfelder'sche Familienstiftung (to C.P.).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 301904 Cancer research
- 104002 Analytical chemistry
- 301206 Pharmacology
Keywords
- Ponatinib
- lipid droplets
- resistance
- cancer
- drug sequestration
- BREAST-CANCER CELLS
- ACCUMULATION
- ROLES
Fingerprint
Dive into the research topics of 'Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver